Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: Involvement of multiple mechanisms

Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: Involvement of multiple mechanisms
复制标题

DOI:
10.1161/01.atv.0000105053.46994.5b
复制
发表时间:
2004-01-01
影响因子:
8.7
通讯作者:
Shimokawa, H
Shimokawa, H
中科院分区:
医学1区
文献类型:
--
作者:
Matsumoto, Y;Uwatoku, T;Shimokawa, H

文献摘要

被引文献

相似文献

我们最近证实Rho激酶,一种小GTdR Rho的效应物,实质上参与动脉硬化的发病机制。在这项研究中,我们研究了Rho激酶是否也参与支架内再狭窄,如果是这样,什么机制involved.Methods和Results-Pigs进行支架植入术在左冠状动脉与或不与管理法舒地尔(30毫克/公斤,每天口服),一个特定的Rho激酶抑制剂,开始2天前的程序持续4周。在第28天,在支架部位观察到与巨噬细胞积聚、胶原沉积和转化生长因子(TGF)-β 1表达相关的冠状动脉直径和新生内膜形成减少,并且所有这些都被法舒地尔显著抑制。在第7天,法舒地尔显着增加TUNEL阳性凋亡细胞的频率,而它倾向于减少新生内膜中溴脱氧尿苷阳性增殖细胞。第7天的蛋白质印迹分析表明ezrin/radixin/moesin家族的磷酸化(体内Rho激酶活性的标志物)和单核细胞趋化蛋白-1和bcl-2的蛋白表达在支架部位上调,并被法舒地尔显著抑制。结论-这些结果表明,长期抑制Rho激酶通过多种机制抑制支架内新生内膜形成,包括减少的血管炎症、增强的细胞凋亡和减少的胶原沉积。
Objective-We recently demonstrated that Rho-kinase, an effector of the small GTPase Rho, is substantially involved in the pathogenesis of arteriosclerosis. In this study, we examined whether Rho-kinase is also involved in in-stent restenosis and if so, what mechanism is involved.Methods and Results-Pigs underwent stent implantation in the left coronary artery with or without administration of fasudil (30 mg/kg per day orally), a specific Rho-kinase inhibitor, starting 2 days before the procedure for a duration of 4 weeks. On day 28, reductions in coronary diameter and neointimal formation associated with macrophage accumulation, collagen deposition, and transforming growth factor (TGF)-beta1 expression were noted at the stent site, and all were significantly suppressed by fasudil. On day 7, fasudil significantly increased the frequency of TUNEL-positive apoptotic cells, while it tended to reduce that of bromodeoxyuridine-positive proliferating cells in the neointima. Western blot analysis on day 7 demonstrated that phosphorylations of the ezrin/radixin/moesin family (a marker of Rho-kinase activity in vivo) and protein expression of monocyte chemoattractant protein-1and bcl-2 were upregulated at the stent site and were significantly suppressed by fasudil.Conclusions-These results indicate that long-term inhibition of Rho-kinase suppresses in-stent neointimal formation by multiple mechanisms, including reduced vascular inflammation, enhanced apoptosis, and decreased collagen deposition.